Top 24 Invenire Partners, Lp Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| HROW | Harrow Health Inc | 8.38% | 453.8K | $5.5M | new | โ | 2022-09-30 | |
| DHX | DHI Group Inc | 7.93% | 964.2K | $5.2M | new | โ | 2022-09-30 | |
| TTI | Tetra Technologies Inc | 6.5% | 1.18M | $4.3M | new | โ | 2022-09-30 | |
| APYX | Apyx Medical Corp | 6.49% | 945.7K | $4.2M | new | โ | 2022-09-30 | |
| INFU | InfuSystem Holdings Inc | 4.99% | 466.7K | $3.3M | new | โ | 2022-09-30 | |
| AREN | Arena Group Holdings Inc | 4.83% | 241.4K | $3.2M | new | โ | 2022-09-30 | |
| CTLP | Cantaloupe Inc | 4.73% | 888.3K | $3.1M | new | โ | 2022-09-30 | |
| PAR | PAR Technology Corp | 4.54% | 100.6K | $3.0M | new | โ | 2022-09-30 | |
| EGIO | Edgio Inc | 4.46% | 1.05M | $2.9M | new | โ | 2022-09-30 | |
| MCS | Marcus Corp | 4.4% | 207.1K | $2.9M | new | โ | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | โ | โ | โ | โ |
| Top 20 Holdings Unweighted | โ | โ | โ | โ |
Invenire Partners, Lp reports $65.27K in US-listed equity holdings across 26 positions in its most recent 13F filing. Its largest disclosed positions are HROW (8.4%), DHX (7.9%) and TTI (6.5%). Figures reflect the Q3 2022 filing.
Sign up free to track Invenire Partners, Lp, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Invenire Partners, Lpโs Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1726823). View Invenire Partners, Lpโs 13F filings on SEC